PRLX-93936 HCL
CAS No. 1094210-96-4
PRLX-93936 HCL( —— )
Catalog No. M34837 CAS No. 1094210-96-4
PRLX-93936 HCL is an analog of erastin and demonstrated synergistic effects against non-small cell lung cancer (NSCLC) cells with cisplatin.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 353 | In Stock |
|
| 10MG | 534 | In Stock |
|
| 25MG | 845 | In Stock |
|
| 50MG | 1107 | In Stock |
|
| 100MG | 1479 | In Stock |
|
| 200MG | 2018 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePRLX-93936 HCL
-
NoteResearch use only, not for human use.
-
Brief DescriptionPRLX-93936 HCL is an analog of erastin and demonstrated synergistic effects against non-small cell lung cancer (NSCLC) cells with cisplatin.
-
DescriptionPRLX-93936 dihydrochloride (Compound 16) is a HIF-1α inhibitor with anticancer activity. PRLX-93936 can inhibit the activated Ras pathway and can be used in the study of relapsed or refractory multiple myeloma.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetFerroptosis
-
RecptorFerroptosis | Reactive Oxygen Species
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1094210-96-4
-
Formula Weight437.37
-
Molecular FormulaC21H26Cl2N4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.Cl.CCOc1ccccc1-n1c(CN2CCNCC2)nc2ccccc2c1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Huang W, et al. Synthesis and evaluation of quinazolin-4-ones as hypoxia-inducible factor-1α inhibitors. Bioorg Med Chem Lett. 2011 Sep 15;21(18):5239-43.?
molnova catalog
related products
-
Cerivastatin
Cerivastatin is an orally active and highly effective HMG-CoA reductase inhibitor with anticancer and lipid-lowering effects.
-
Piperazine Erastin
Piperazine Erastin is an analog of Erastin, which can induces ferroptosis in cancer cells, an iron-dependent form of nonapoptotic cell death.
-
iFSP1
iFSP1 is able to sensitize a variety of human cancer cell lines to the ferroptosis inducer, such as (1S,3R)-RSL3.iFSP1 is a potent, selective and glutathione-independent inhibitor of ferroptosis suppressor protein 1 (FSP1) (AIFM2) with an EC50 of 103 nM.
Cart
sales@molnova.com